BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12203787)

  • 1. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.
    Nakata T; Yokota T; Emi M; Minami S
    Genes Chromosomes Cancer; 2002 Sep; 35(1):30-7. PubMed ID: 12203787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma.
    Nakata T; Kitamura Y; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Emi M
    Genes Chromosomes Cancer; 1999 Jun; 25(2):97-103. PubMed ID: 10337992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
    Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
    Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
    Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
    Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic organization and chromosomal mapping of ELKS, a gene rearranged in a papillary thyroid carcinoma.
    Yokota T; Nakata T; Minami S; Inazawa J; Emi M
    J Hum Genet; 2000; 45(1):6-11. PubMed ID: 10697956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
    Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
    Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
    Bongarzone I; Butti MG; Coronelli S; Borrello MG; Santoro M; Mondellini P; Pilotti S; Fusco A; Della Porta G; Pierotti MA
    Cancer Res; 1994 Jun; 54(11):2979-85. PubMed ID: 8187085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.
    Sozzi G; Bongarzone I; Miozzo M; Borrello MG; Blutti MG; Pilotti S; Della Porta G; Pierotti MA
    Genes Chromosomes Cancer; 1994 Apr; 9(4):244-50. PubMed ID: 7519046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
    Salassidis K; Bruch J; Zitzelsberger H; Lengfelder E; Kellerer AM; Bauchinger M
    Cancer Res; 2000 Jun; 60(11):2786-9. PubMed ID: 10850414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein.
    Mercalli E; Ghizzoni S; Arighi E; Alberti L; Sangregorio R; Radice MT; Gishizky ML; Pierotti MA; Borrello MG
    Oncogene; 2001 Jun; 20(27):3475-85. PubMed ID: 11429694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene.
    Tong Q; Li Y; Smanik PA; Fithian LJ; Xing S; Mazzaferri EL; Jhiang SM
    Oncogene; 1995 May; 10(9):1781-7. PubMed ID: 7753554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
    Fugazzola L; Pierotti MA; Vigano E; Pacini F; Vorontsova TV; Bongarzone I
    Oncogene; 1996 Sep; 13(5):1093-7. PubMed ID: 8806699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
    Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
    Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8).
    Klugbauer S; Jauch A; Lengfelder E; Demidchik E; Rabes HM
    Cancer Res; 2000 Dec; 60(24):7028-32. PubMed ID: 11156407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
    Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
    Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.
    Klugbauer S; Rabes HM
    Oncogene; 1999 Jul; 18(30):4388-93. PubMed ID: 10439047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.
    Reynolds L; Jones K; Winton DJ; Cranston A; Houghton C; Howard L; Ponder BA; Smith DP
    Oncogene; 2001 Jul; 20(30):3986-94. PubMed ID: 11494127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.